According to the latest market research study released by Technavio, the global hospital-acquired UTI testing market is expected to grow at a CAGR of around 19% during the forecast period 2016-2020.
This market research report by Technavio provides an in-depth analysis of the market in terms of revenue and emerging market trends. The report also includes an up-to-date analysis and forecasts for various market segments and all geographical regions.
Click here to request a free sample of this report
Technavio research analysts categorize the global hospital-acquired UTI testing market based on technology:
Global hospital-acquired UTI testing market shares by technology 2015
|
Conventional |
59.23% |
|
Imaging techniques |
28.46% |
|
Point of care |
12.31% |
Source: Technavio
Conventional method
The conventional method, mainly comprising urinalysis, accounted for around 59% of the global hospital-acquired UTI testing market. Urinalysis mainly deals with urine culturing. Urine culture tests are often outsourced to the diagnostic centers, independent reference laboratories, and hospital outpatient laboratories. A positive urine culture tests are tested to identify organisms and to check its susceptibility to antibiotics.
“The urine culture tests are the gold standard for the detection of UTIs. It is anticipated to be the most preferred method to trace urinary infections during the forecast period, primarily due to its low-cost. None of the alternative methods have the potential to eliminate the use of conventional method, which continues to be used as a confirmative test in the diagnosis of UTI,” says Barath Palada, a lead analyst at Technavio for research on in-vitro diagnostics.
Imaging tests
Imaging devices provide pictures of bones and organs inside the body. Imaging techniques helps physicians to see the causes of urinary infection. Some of the most popular imaging techniques include ultrasound, cystoscopy, X-rays, CT, and magnetic resonance imaging (MRI). Imaging tests are applied to observe the anatomical problems and signs of some underlying diseases that cause UTIs. These tests are often prescribed for children with a frequent occurrence of UTIs. Advanced imaging techniques are widely used to detect UTIs within a very short period, which is compelling the vendors to reduce the price of imaging devices by miniaturizing them. CT is a broadly accepted imaging technique in hospitals and has gained acceptance as a more sensitive modality for diagnosis and follow-up of complicated renal tract infection. CT gives a very detailed three-dimensional picture of the urinary tract and can identify significant complications or obstruction and define the extent of disease. Cystoscopy can detect the abnormalities inside the bladder that cause UTIs.
Point of care testing
POC testing is the fastest-growing segment of laboratory diagnostics worldwide. The POC urinalysis tests can detect accurate results within minutes and are quite inexpensive and widely acceptable in the market. The companies in this market segment include Siemens Healthineers and Alere, which offer products that have high sensitivity to detect urinalysis. POC testing is performed using electronic and non-electronic devices that range from reaction strips to large devices, which replace a series of laboratory experiments and reduce the turnaround time. These diagnostic devices are categorized into hand-held and near-bedside monitoring devices. The hand-held POC testing devices are small and offer mobility, whereas the near-bedside POC testing devices are large and complex. For both the devices, quality control and calibration functionality are checked before performing the tests.
Accuracy streamlined workflow and efficiency will make POCT tests a preferred choice for physicians. There will be a paradigm shift toward personalized patient care and better clinical outcomes which will fuel the market growth during the forecast period. The growing preference for home-care POCT settings will also contribute to the growth of this market segment.
The top leading vendors operating in the global hospital-acquired UTI testing market are:
- bioMérieux
- Roche Diagnostics
- Siemens Healthineer
Other prominent vendors in the market include ACON Laboratories, Alere, ARKRAY, Beckman Coulter, Becton Dickinson and Company (BD), Bio-Rad, Cepheid, Labomed, Mindray, Sysmex, Thermo Fisher Scientific, and URIT Medical.
A more detailed analysis is available in the Technavio report titled, ‘Global Hospital-Acquired UTI Testing Market 2016-2020’. Technavio also customizes reports by other regions and specific segments upon request.
Other related reports:
- Global Urinary Catheters Market 2016-2020
- Global Hospital Infection Therapeutics Market 2015-2019
- Global Urinary Incontinence Products Market 2015-2019
To read more press releases- click here.
For any assistance or query, please contact our media team at:
media@technavio.com
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com
